BIOAFFINITY TECHNOLOGIES INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$2.91
-3.96%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-52.6%
3 months
-67.5%
6 months
-91.1%
1 year
-92.0%
Year to date
-83.6%
52-week range
$2.80 – $71.10
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.6M
P/E
-0.1
P/B
0.4
P/S
0.3
Revenue
$5.9M
Net income
-$15.19M
Diluted EPS
-109.7
Gross margin
34.60%
Net margin
-257.30%
Return on equity
-257.30%
Total debt
$1.44M
Cash
$2.43M
Free cash flow
-$11.56M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $1.51M | -$3.37M | 28.00% | -222.80% | -$3.29M |
| Mar 31, 2026 | $1.35M | -$3.63M | 31.30% | -268.60% | -$3.23M |
| Dec 31, 2025 | $1.59M | -$3.14M | 43.50% | -197.00% | -$2.56M |
| Sep 30, 2025 | $1.45M | -$5.05M | 34.80% | -349.30% | -$2.48M |
| Jun 30, 2025 | $1.27M | -$4.06M | 19.90% | -319.90% | -$2.66M |
| Mar 31, 2025 | $1.85M | -$2.66M | 26.20% | -143.50% | -$1.69M |
| Dec 31, 2024 | $2.21M | -$2.97M | 29.20% | -134.40% | -$1.68M |
| Dec 31, 2024 | $2.21M | -$2.97M | 29.20% | -134.40% | -$1.68M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent BIAF news
All market newsNo ticker-linked stories are in the current archive.